EPISODE · Jun 18, 2026 · 22 MIN
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
from JAMA Medical News
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
NOW PLAYING
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m